Clinical trials: Radio Dermatitis
Radio Dermatitis, Mucositis Oral
Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy
The goal of this interventional study is to see if the daily use of red light therapy called photobiomodulation can help sore skin and sore mouths in children having radiotherapy.
- Conditions
- Radio Dermatitis, Mucositis Oral, Oesophagitis
- Trial name
- RADIANT (NCT07183267)
- Testing
- Photobiomodulation
- Where
- United Kingdom
- Volunteers
- 248 people
- Sponsor
- The Christie NHS Foundation Trust
Epigallocatechin Gallate, Radio Dermatitis
Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis
Radiodermatitis and radiation mucositis were the most frequent side-effect during the course of radiotherapy, especially when concurrent chemoradiotherapy applied.
- Conditions
- Epigallocatechin Gallate, Radio Dermatitis, Radiation Mucositis
- Trial name
- NCT01481818
- Testing
- EGCG
- Volunteers
- 15 people
- Sponsor
- Shandong Cancer Hospital and Institute
Breast Cancer, Radio Dermatitis
Autologous Fat Infiltration Versus General Measures as Treatment in Radiodermatitis Induced for Radiotherapy in Breast Cancer Patients
Radiodermatitis is a major problem in oncologic patients, fat grafts previously used for cosmetic procedures have been shown to have regenerative power due to their stem cell content.
- Conditions
- Breast Cancer, Radio Dermatitis, Radiotherapy
- Trial name
- NCT07023796
- Testing
- Autologous fat filtration
- Where
- Mexico
- Volunteers
- 22 people
- Sponsor
- Instituto Mexicano del Seguro Social
Breast Cancer, Radio Dermatitis
Photobiomodulation in Radiodermatitis in People With Breast Cancer
Most breast cancer patients undergoing radiotherapy develop radiodermatitis, making it one of the most prevalent adverse events during cancer treatment.
- Trial name
- NCT06990165
- Testing
- Photobiomodulation
- Where
- 2 sites in Brazil
- Volunteers
- 148 people
- Sponsor
- Instituto Nacional de Cancer, Brazil
Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy
Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis
Most patients with cancer or haematological malignancies who receive chemotherapy - broadly defined to include targeted therapies and immunotherapy - and/or external beam radiotherapy may experience serious and disabling adverse…
- Conditions
- Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy, Oral Mucositis (Ulcerative) Due to Radiation, Dermatitis
- Trial name
- NéoPBM (NCT07054528)
- Where
- France
- Volunteers
- 33,000 people
- Sponsor
- Centre Hospitalier de Valenciennes
Radio Dermatitis, Polarized Light
Polarized Light Therapy for Radiation Dermatitis in Breast Cancer
This assessor-blinded randomized controlled trial aims to evaluate the efficacy of polarized polychromatic non-coherent light therapy as an adjunct to standard skin care in reducing acute radiation dermatitis in women with breast…
- Conditions
- Radio Dermatitis, Polarized Light, Breast Cancer Survivors
- Trial name
- PLARD-BREAST (NCT07600957)
- Testing
- Polarized Polychromatic Light Therapy, Standard Skin Care
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Beni-Suef University
Head and Neck Carcinoma
Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®
The aim of this randomized trial is to compare the rate of radio-dermatitis grade 2+ (NCI-CTC V3.0) in patients receiving radiotherapy+Erbitux+placebo versus in patients receiving radiotherapy+Erbitux+OTD70DERM® for the treatment…
- Trial name
- GORTEC 2009-01 (NCT01228565)
- Testing
- Radiotherapy+Erbitux+OTD70DERM
- Where
- 5 sites in France
- Volunteers
- 76 people
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
Breast Cancer, Radiation Dermatitis
Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial
The primary objective consisted of avoiding deterioration and/or restoring the integrity of the skin of patients treated by radiotherapy, right from the first signs of grade 1 or 2 radiation dermatitis.
- Trial name
- HYDROSORB (NCT02839473)
- Testing
- Castalie water spray, Hydrogel Hydrosorb®
- Where
- 2 sites in France
- Volunteers
- 278 people
- Sponsor
- Institut Curie
Radiation Dermatitis
Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis
The purpose of this study is to characterize the skin microbiome profile of breast cancer patients before and after receiving Radio Therapy treatments, and evaluate the relationship between the microbiome profile and radiation…
- Trial name
- NCT04268056
- Testing
- Collection of skin culture samples
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- AceTech